Heterozygous methylenetetrahydrofolate reductase 677C-T gene mutation with mild hyperhomocysteinemia associated with intrauterine iliofemoral artery thrombosis

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 6, 2006, Pages 495-498

  Alioglu, Bulent ^a   Ozyurek, Emel ^a   Tarcan, Aylin ^a   Atac, F Belgin ^a   Gurakan, Berkan ^a   Ozbek, Namik ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Intrauterine thrombosis; Methylenetetrahydrofolate reductase 677C T gene mutation; Mild hyperhomocyteinemia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTERY THROMBOSIS; ARTICLE; CASE REPORT; GENE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; INFANT; MALE; NEWBORN SCREENING; PRIORITY JOURNAL; THROMBOEMBOLISM;

ANGIOPLASTY, BALLOON; FEMORAL ARTERY; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; ILIAC ARTERY; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; STREPTOKINASE; THROMBOSIS;

EID: 33747201659     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000240925.03425.c0     Document Type: Article

References (24)

1. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76:F163-F167.
2. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96:939-943.
3. Nowak-Gottl U, Duering C, Kempf-Bielack B, Strater R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 2003/2004; 33:269-274.
4. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child 1999; 81:176-178.
5. Moazzam A, Riaz M, Brennen MD. Neonatal gangrene in an extremity of an infant of a diabetic mother. BJOG 2003; 110:74-76.
6. Long DK, Lorant DE. Multiple arterial thrombi and in utero leg gangrene in an infant of a diabetic mother. J Perinatol 2002; 22:424-427.
7. Strobelt N, Mariani E, Locatelli A, Fedeli T, D'Alessio A. Threatened premature delivery with prolapsed amniotic sac leading to neonatal limb gangrene. Acta Obstet Gynecol Scand 2000; 79:805-806.
8. Letts M, Blastorah B, al-Azzam S. Neonatal gangrene of the extremities. J Pediatr Orthop 1997; 17:397-401.
9. Blank JE, Dormans JP, Davidson RS. Perinatal limb ischemia: orthopaedic implications. J Pediatr Orthop 1996; 16:90-96.
10. Scott F, Evans N. Distal gangrene in a polycythemic recipient fetus in twin-twin transfusion. Obstet Gynecol 1995; 86:677-679.
11. Couto FD, Adorno EV, Menezes JF, Moura Neto JP, Rego MA, Reis MG, et al. C677T polymorphism of the MTHFR gene and variant hemoglobins: a study in newborns from Salvador, Bahia, Brasil. Cad Saude Publica 2004; 20:529-533.
12. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, et al. Geographical and ethnic variation of the 677C-T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003; 40:619-625.
13. Den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334:759-762.
14. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylene tetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93:7-9.
15. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arterioscler Thromb Vasc Biol 1994; 14:1080-1083.
16. Pathare A, Alkindi S, Albalushi T, Bayoumi R, Dennison D, Muralitharan S. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Clin Lab Haemost 2004; 26:143-146.
17. Amundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients deep venous thrombosis. Arterioscler Thromb Vasc Biol 1995; 15:1321-1323.
18. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999; 81:165-176.
19. van der Molen EF, Arends GE, Nelen WL, van der Put NJ, Heil SG, Eskes TK, Blom HJ. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol 2000; 182:1258-1263.
20. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95:2032-2036.
21. Legnani C, Palareti G, Grauso F, Sassi S, Grossi G, Piazzi S, et al. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects. Arterioscler Thromb Vasc Biol 1997; 17:2924-2929.
22. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss [letter]. Lancet 1997; 350:861.
23. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Factor V Leiden, C T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997; 77:1052-1054.
24. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, Fitzgerald DJ. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphism in pregnancy. Arterioscler Thromb Vasc Biol 2000; 20:266-270.